EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low cost, high temporal resolution optical fiber-based γ-photon sensor for real-time pre-clinical evaluation of cancer-targeting radiopharmaceuticals

Rahul Lall, Kyoungtae Lee, Shalini Chopra, Averal Kandala, Michael Evans, Youngho Seo, Ali Niknejad, Mekhail Anwar

Biosensors and Bioelectronics · 2024-03 · 247 · 115956

DOI: 10.1016/j.bios.2023.115956 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2024-03. Verfasst von Rahul Lall und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical Engineering and Computer Science, University of California, Berkeley, Berkeley, CA, 94720, USA. Electronic address: rklall@b…. Hauptthemen laut MEDLINE: Biosensing Techniques, Prostatic Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer radiopharmaceutical therapies (RPTs) have demonstrated great promise in the treatment of neuroendocrine and prostate cancer, giving hope to late-stage metastatic cancer patients with currently very few treatment options. These therapies have sparked a large amount of interest in pre-clinical research due to their ability to target metastatic disease, with many research efforts focused towards developing and evaluating targeted RPTs for different cancer types in in vivo models. Here we describe a method for monitoring real-time in vivo binding kinetics for the pre-clinical evaluation of cancer RPTs. Recognizing the significant heterogeneity in biodistribution of RPTs among even genetically identical animal models, this approach offers long-term monitoring of the same in vivo organism without euthanasia in contrast to ex vivo tissue dosimetry, while providing high temporal resolution with a low-cost, easily assembled platform, that is not present in small-animal SPECT/CTs. The method utilizes the developed optical fiber-based γ-photon biosensor, characterized to have a wide linear dynamic range with Lutetium-177 (177Lu) activity (0.5-500 μCi/mL), a common radioisotope used in cancer RPT. The probe's ability to track in vivo uptake relative to SPECT/CT and ex vivo dosimetry techniques was verified by administering 177Lu-PSMA-617 to mouse models bearing human prostate cancer tumors (PC3-PIP, PC3-flu). With this method for monitoring RPT uptake, it is possible to evaluate changes in tissue uptake at temporal resolutions

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesProstatic NeoplasmsMaleAnimalsMiceHumansRadiopharmaceuticalsGlutamate Carboxypeptidase IITissue DistributionOptical FibersProstate-Specific AntigenLutetium

Stichwörter der Autor:innen

Cancer radiotherapyDosimetryMetastatic diseasePre-clinicalRadiopharmaceutical therapyScintillation detectors

Substanzen

RadiopharmaceuticalsGlutamate Carboxypeptidase IIProstate-Specific AntigenLutetium

Autor:innen und Institutionen

  • Department of Electrical Engineering and Computer Science, University of California, Berkeley, Berkeley, CA, 94720, USA. Electronic address: rklall@berkeley.edu.
  • Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA, 94107, USA.
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, 94107, USA.
  • Department of Electrical Engineering and Computer Science, University of California, Berkeley, Berkeley, CA, 94720, USA.
  • Department of Electrical Engineering and Computer Science, University of California, Berkeley, Berkeley, CA, 94720, USA; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA, 9410…

Förderung

  • U.S. Department of Defense
  • National Science Foundation

Zitieren

APA

Lall, R., Lee, K., Chopra, S., Kandala, A., Evans, M., Seo, Y., Niknejad, A., & Anwar, M. (2024). Low cost, high temporal resolution optical fiber-based γ-photon sensor for real-time pre-clinical evaluation of cancer-targeting radiopharmaceuticals. Biosensors and Bioelectronics, 247, 115956. https://doi.org/10.1016/j.bios.2023.115956

Vancouver

Lall R, Lee K, Chopra S, Kandala A, Evans M, Seo Y, et al. Low cost, high temporal resolution optical fiber-based γ-photon sensor for real-time pre-clinical evaluation of cancer-targeting radiopharmaceuticals. Biosensors and Bioelectronics. 2024;247:115956. doi:10.1016/j.bios.2023.115956

BibTeX
@article{Lall2024,
  author = {Lall, Rahul and Lee, Kyoungtae and Chopra, Shalini and Kandala, Averal and Evans, Michael and Seo, Youngho and Niknejad, Ali and Anwar, Mekhail},
  title = {Low cost, high temporal resolution optical fiber-based γ-photon sensor for real-time pre-clinical evaluation of cancer-targeting radiopharmaceuticals},
  journal = {Biosensors and Bioelectronics},
  year = {2024},
  volume = {247},
  pages = {115956},
  doi = {10.1016/j.bios.2023.115956}
}
Kostenlos starten →